Younger Kidney Cancer Patients on VEGF Inhibitors at Elevated Risk for Hypertension
WEDNESDAY, July 26, 2023 (HealthDay News) — Hypertension during treatment is common among adolescents and young adults (AYAs) being treated with vascular endothelial growth factor (VEGF) inhibitors for renal cancer, according to a study published onl…
Learn MoreASCO: Adding Atezolizumab to Cabozantinib No Benefit in Advanced Renal Cancer
FRIDAY, June 9, 2023 (HealthDay News) — For patients with locally advanced or metastatic renal cell carcinoma with disease progression on or after immune checkpoint inhibitor treatment, the addition of atezolizumab to cabozantinib does not improve cl…
Learn MoreCabozantinib Plus Nivolumab and Ipilimumab Increases PFS in Renal Cell Cancer
THURSDAY, May 11, 2023 (HealthDay News) — Cabozantinib plus nivolumab and ipilimumab yields significantly longer progression-free survival than treatment with cabozantinib plus nivolumab alone among patients with previously untreated, advanced renal-…
Learn MoreUrothelial Cancer Prediction Model Has High Sensitivity, Specificity
TUESDAY, March 21, 2023 (HealthDay News) — A urothelial cancer (UC) prediction model, which considers 10 genes with the highest performance from the UroAmp urinary comprehensive genomic profiling (uCGP) test, has high sensitivity and specificity, acc…
Learn MoreBenefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 (HealthDay News) — For patients with advanced renal cell carcinoma, progression-free survival and overall survival are improved with lenvatinib plus pembrolizumab versus sunitinib, according to a study published in the March is…
Learn MoreUGN-101 Reviewed in Real-World Upper Tract Urothelial Cancer Setting
MONDAY, Jan. 9, 2023 (HealthDay News) — For patients with upper tract urothelial cancers (UTUCs), the novel therapeutic UGN-101 seems to be effective, with an acceptable safety profile, according to research published online Nov. 22 in Urologic Oncol…
Learn MoreTrends in Genitourinary Cancers Examined in the United States
WEDNESDAY, Dec. 21, 2022 (HealthDay News) — The highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a study published online D…
Learn MoreCryoablation More Effective for Some Early-Stage Renal Cell Carcinomas
MONDAY, Dec. 5, 2022 (HealthDay News) — For patients with early-stage renal cell carcinoma, heat-based thermal ablation is associated with increased cancer-specific mortality with tumor size 3.1 to 4 cm, while cancer-specific mortality is similar for…
Learn MorePatients Favor Single-Port Robotic System for Uro-Oncology Surgery
MONDAY, Oct. 31, 2022 (HealthDay News) — For patients undergoing urologic oncology procedures, use of the da Vinci single-port (SP) robotic system is perceived favorably by patients compared with a multiport platform, according to a study published i…
Learn MoreTriplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced r…
Learn More